IO Biotech, Inc. (IOBTQ) Free cash flow 2021–2024
IO Biotech, Inc. (IOBTQ) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$82.4MFY2024 · since FY2021: -$40.8M → -$82.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$82.4M | -14.3% |
| FY2023 | -$72.1M | -19.3% |
| FY2022 | -$60.4M | -48.1% |
| FY2021 | -$40.8M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice